Free Access
Issue |
Med Sci (Paris)
Volume 18, Number 4, Avril 2002
|
|
---|---|---|
Page(s) | 398 - 400 | |
Section | Le Magazine : Nouvelles | |
DOI | https://doi.org/10.1051/medsci/2002184398 | |
Published online | 15 April 2002 |
- Jiang XC, Bruce C, Mar J, et al. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest 1999; 103 : 907–14. [Google Scholar]
- Jiang XC, Qin S, Qiao C, et al. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat Med 2001; 7 : 847–52. [Google Scholar]
- Albers JJ, Tu AY, Paigen B, Chen H, Cheung MC, Marcovina SM. Transgenic mice expressing human phospholipid transfer protein have increased HDL/non-HDL cholesterol ratio. Int J Clin Lab Res 1996; 26 : 262–7. [Google Scholar]
- Van Haperen R, van Tol A, Vermeulen P, et al. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol 2000; 20 : 1082–8. [Google Scholar]
- Desrumaux C, Deckert V, Athias A, et al. Plasma phospholipid transfer protein prevents vascular endothelium dysfunction by delivering alpha-tocopherol to endothelial cells. FASEB J 1999; 13 : 883–92. [Google Scholar]
- Jiang XC, Qin S, Lin M, et al. Phospholipid transfer protein (PLTP) deficiency represents an anti-oxidant state in mice. Circulation 2001; 104 : II–232. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.